Skip to main content

Table 2 Demographic characteristics and history of hospitalization abroad of patients colonized or infected with CRO, Frankfurt/Main, 1.4.2012- 31.03.2013

From: Burden of carbapenem-resistant organisms in the Frankfurt/Main Metropolitan Area in Germany 2012/2013 – first results and experiences after the introduction of legally mandated reporting

  Total P. aeruginosa A. baumannii K. pneumoniae E. coli Enterobacter
Total 243a 153 28 33 13 12
Age (years) (mean) 58.9 ± 20.1 59.5 ± 19.7 53.1 ± 17.2 59.4 ± 19.5 59.2 ± 23.3 58,0 ± 30,7
Age range (years) 0-97 0-97 18-84 0-90 2-91 0-89
Percentage of male patients 66.7 60.1 82.1 81.8 61.5 83.3
Hospitalization abroad during previous 6 months 32 patientsb N = 10 N = 11 N = 7 N = 2 N = 1
Iran Egypt Egypt Qatar Sri Lanka
Kuwait Brasil Greece India  
Brasil Ukraine Nicaragua   
Qatar Qatar Italy   
India Kosovo India (n = 2)   
Egypt Russia Turkey   
Nicaragua India    
Venezuela Thailand    
Russia (n = 2)    
Macedonia Turkey    
  Morocco    
Place of residence abroad N = 21 (8.6%) N = 11 N = 6 N = 2 N = 2  
Egypt Algeria Egypt India  
Iran Egypt India Egypt  
India Qatar    
Kuwait Kuwait    
Macedonia Russia (n = 2)    
Qatar (n = 2)     
Russia     
Saudi Arabia     
Ukraine     
Venezuela     
Infection (%) 29.7 24.2 28.6 30.3 23.1 50.0
Carbapenemase (cases) 32 casesc Metallo-ß-lactamase, unspecified (n = 3) OXA-23-like (n = 7) OXA-23-like (n = 1) OXA-48 (n = 4)  
VIM-1 (n = 1) NDM-1 (n = 1) OXA-48 (n = 4) NDM-7 (n = 1)  
VIM-2 (n = 3)   NDM, not further specified (n = 3)   
   KPC-2 (n = 1)   
   KPC-3 (n = 1)   
  1. aincluding C. koseri, E. sakazakii. 1 K. oxytoca, P mirabilis.
  2. bincluding 1 patient, C. koseri Libya.
  3. cincluding OXA-48 (n = 1) from C. koseri; NDM1/6 (n = 1) from K. oxytoca.